Onepot AI lands $13M to simplify Small-Molecule Drug Synthesis
The idea behind Onepot AI emerged from a shared frustration experienced by co-founders Daniil Boiko and Andrei Tyrin: in modern drug discovery, the most innovative therapeutic concepts often stall long before reaching the lab bench.

The best Articles in our Network